Regeneron Pharmaceuticals beat fourth-quarter sales and profit estimates on Tuesday, on continuing demand for its eczema treatment, Dupixent, and announced a dividend and stock buyback program ...

Genentech, a member of Roche (RHHBY), announced that a detailed analysis of its Phase III REGENCY trial of Gazyva in people with active lupus nephritis was published in the New England Journal of ...

The new project is also remarkable because it advances PatientsLikeMe's work with pharma – the research is being funded by AstraZeneca (AZ) and Genentech (Roche's biotech arm), both of which ...

(RTTNews) - Genentech, a member of the Roche Group (RHHBY), announced that the U.S. Food and Drug Administration has approved Susvimo (ranibizumab injection) 100 mg/mL for the treatment of ...

The last step is a short wait for your results to arrive digitally. A DNA test allows you to learn more about your heritage, health, genetic conditions, family history and potential genetic ...

The PATHWAY HER2 (4B5) test ... based at Genentech in South San Francisco. In this new role, she will take over the worldwide responsibility for the Informatics function for the Roche Group ...

Roche, the parent company of Indianapolis-based Roche Diagnostics, said it received FDA clearance to sell a new test to help determine a patient’s risk of an often untested but common ...

1 The Roche Diagnostics Tina-quant® Lipoprotein (a) Gen.2 Molarity assay is an in-vitro test measuring lipoprotein ... to achieve net zero by 2045. Genentech, in the United States, is a wholly ...

Investing.com -- Roche's experimental Parkinson's disease drug ... ByInvesting.com • 19 Dec 2024 New and Updated Data for Genentech's Fixed-Duration Columvi and Lunsumio at ASH 2024 Reinforce Their ...

(KNSI) – Chronic wasting disease continues to spread in Minnesota after two deer tested positive for the deadly disease across two areas. According to the Minnesota Department of Natural ...

Roche’s freshly approved PI3K inhibitor Itovebi can help extend the lives of certain patients with breast cancer when used in combination with two established medicines, new survival data from ...